The call comes amidst a pile of controversies surrounding the use of AstraZeneca, which was initially marketed as the vaccine for the world. The use of the vaccine has been suspended in a number of countries following multiple reports of blood clotting developing in people after vaccination. There have also been concerns over the efficacy of the vaccine in people aged above 65.
